Dennis Alicia T, Ferguson Marissa, Jackson Sarah
The Royal Women's Hospital, Locked Bag 300, Corner Grattan St. & Flemington Rd., Parkville, Victoria, 3052, Australia.
School of Medicine, Faculty of Health, Deakin University, Geelong, Australia.
Perioper Med (Lond). 2022 Aug 4;11(1):36. doi: 10.1186/s13741-022-00268-x.
Caesarean section is a common surgery, with almost 23 million procedures performed globally each year. Postpartum haemorrhage, in association with caesarean section surgery, is a leading global cause of maternal morbidity and mortality. Perioperative iron deficiency anaemia is a risk factor for intraoperative bleeding. Therefore, anaemia is an important and modifiable risk factor for bleeding during caesarean section surgery. Recent recommendations advise that all preoperative patients with anaemia (defined as haemoglobin concentration (Hb) < 130 g/L), regardless of sex, be assessed and treated to normalise haemoglobin levels. It is unclear how this recommendation translates to pregnant women where the World Health Organization (WHO) defines anaemia at a much lower threshold (Hb < 110 g/L). We aimed to determine the prevalence, and characterization, of Hb levels < 130 g/L perioperatively in women undergoing caesarean section.
We conducted a retrospective cohort study of 489 consecutive women who underwent caesarean section over a 12-week period, in a single-centre tertiary referral maternity unit in Australia. We calculated the proportion of women who were anaemic (Hb < 130 g/L) at four time points-first hospital appointment, third trimester, preoperatively and on discharge from hospital. The proportion of women who were iron deficient (ferritin level < 30 μg/L) at their first hospital appointment was determined.
Haemoglobin was measured in 479 women. Ferritin was measured in 437 of these women. The mean (SD) Hb at the first hospital appointment, third trimester, preoperatively, and postoperatively on discharge was 126.7 (11.4) g/L, 114.6 (10.6) g/L, 124.1 (12.4) g/L, and 108.0 (13.6) g/L respectively. Iron deficiency was present in 148 (33.9%) women at their first hospital appointment; 107 of 248 (43.1%) women with anaemia and 41 of 189 (21.7%) with no anaemia. 29 women were found to have moderate anaemia (Hb 80-109 g/L) with 18 of these 29 (62.1%) women having iron deficiency. Only 68 (45.9%) women with iron deficiency at their first hospital appointment received treatment. The prevalence of anaemia classified as Hb < 130 g/L versus the WHO classification of Hb < 110 g/L from all causes was 57.4% versus 6.1% at first hospital appointment, 94% versus 26.1% in third trimester, and 66.0% versus 12.2% preoperatively. Postoperatively at least 40% of women had Hb < 130 g/L on hospital discharge versus at least 23% of women using WHO definition of Hb < 110 g/L. Of the 112 women with hospital discharge Hb < 110 g/L, 35 (31.3%) women were iron deficient at their first hospital appointment.
Over one in three women were iron deficient at their first hospital appointment. 62% of women with moderate anaemia (Hb 80-109 g/L) also had iron deficiency. At least four in 10 women were anaemic (Hb < 130 g/L) on hospital discharge. Less than half of the women with anaemia were treated. Our data suggests that 30% of postoperative anaemia may be prevented with intensive treatment of iron deficiency in early pregnancy. Large prospective studies, are needed to determine outcomes after caesarean section in women, stratified by preoperative Hb and ferritin levels. The prevalence of anaemia in our data suggests it is a moderate public health problem.
剖宫产是一种常见手术,全球每年实施近2300万例。与剖宫产手术相关的产后出血是全球孕产妇发病和死亡的主要原因。围手术期缺铁性贫血是术中出血的一个危险因素。因此,贫血是剖宫产手术中出血的一个重要且可改变的危险因素。最近的建议指出,所有术前贫血患者(定义为血红蛋白浓度(Hb)<130 g/L),无论性别,都应进行评估和治疗,以使血红蛋白水平恢复正常。目前尚不清楚该建议如何适用于世界卫生组织(WHO)将贫血定义阈值定得低得多(Hb<110 g/L)的孕妇。我们旨在确定剖宫产妇女围手术期Hb水平<130 g/L的患病率及其特征。
我们在澳大利亚一家单中心三级转诊产科单位,对连续12周内接受剖宫产的489名妇女进行了一项回顾性队列研究。我们计算了四个时间点贫血(Hb<130 g/L)妇女的比例,这四个时间点分别为首次医院就诊、孕晚期、术前和出院时。确定了首次医院就诊时缺铁(铁蛋白水平<30 μg/L)妇女的比例。
对479名妇女进行了血红蛋白测量。其中437名妇女进行了铁蛋白测量。首次医院就诊、孕晚期、术前和出院后术后的平均(标准差)Hb分别为126.7(11.4)g/L、114.6(10.6)g/L、124.1(12.4)g/L和108.0(13.6)g/L。148名(33.9%)妇女在首次医院就诊时存在缺铁;248名贫血妇女中有107名(43.1%),189名无贫血妇女中有41名(21.7%)。发现29名妇女患有中度贫血(Hb 80 - 109 g/L),这29名妇女中有18名(62.1%)缺铁。首次医院就诊时缺铁的妇女中只有68名(45.9%)接受了治疗。首次医院就诊时,按照Hb<130 g/L分类的贫血患病率与WHO按照Hb<110 g/L分类的所有原因导致的贫血患病率分别为57.4%对6.1%,孕晚期为94%对26.1%,术前为66.0%对12.2%。术后至少40%的妇女出院时Hb<130 g/L,而按照WHO Hb<110 g/L的定义至少23%的妇女贫血。在112名出院时Hb<110 g/L的妇女中,35名(31.3%)妇女在首次医院就诊时缺铁。
超过三分之一的妇女在首次医院就诊时缺铁。62%的中度贫血(Hb 80 - 109 g/L)妇女也缺铁。至少十分之四的妇女出院时贫血(Hb<130 g/L)。不到一半的贫血妇女得到了治疗。我们的数据表明,通过在孕早期强化治疗缺铁,可预防30%的术后贫血。需要进行大型前瞻性研究,以确定根据术前Hb和铁蛋白水平分层的妇女剖宫产术后结局。我们数据中贫血的患病率表明这是一个中度的公共卫生问题。